Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line

Br J Cancer. 1992 Apr;65(4):498-502. doi: 10.1038/bjc.1992.103.

Abstract

The doxorubicin-selected multidrug resistant small cell lung cancer cell line, H69AR, is cross-resistant to the Vinca alkaloids and epipodophyllotoxins, but does not overexpress P-glycoprotein, a 170 kDa plasma membrane efflux pump usually associated with this type of resistance. Monoclonal antibodies were raised against the H69AR cell line and one of these, MAb 3.186, recognises a peptide epitope on a 36 kDa phosphorylated protein that is membrane associated, but not presented on the external surface of H69AR cells (Mirski & Cole, 1991). In the present study, in vitro translation and molecular cloning techniques were used to determine the relative levels of mRNA corresponding to the 3.186 antigen. In addition, a cDNA clone containing an insert of approximately 1.4 kb was obtained by screening an H69AR cDNA library with 125I-MAb 3.186. Fragments of this cloned DNA hybridised to a single mRNA species of approximately 1.6 kb that was 5 to 6-fold elevated in H69AR cells. Partial DNA sequencing and restriction endonuclease mapping revealed identity of the cloned DNA with p36, a member of the annexin/lipocortin family of Ca2+ and phospholipid binding proteins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Annexins
  • Antibodies, Monoclonal
  • Calcium-Binding Proteins / metabolism*
  • Carcinoma, Small Cell / metabolism*
  • DNA / genetics
  • Drug Resistance*
  • Gene Expression
  • Humans
  • Lung Neoplasms / metabolism*
  • Precipitin Tests
  • RNA, Messenger / genetics
  • Restriction Mapping
  • Tumor Cells, Cultured

Substances

  • Annexins
  • Antibodies, Monoclonal
  • Calcium-Binding Proteins
  • RNA, Messenger
  • DNA